Literature DB >> 28069159

Developing a new PI-RADS v2-based nomogram for forecasting high-grade prostate cancer.

X-K Niu1, W-F He2, Y Zhang3, S K Das4, J Li5, Y Xiong1, Y-H Wang6.   

Abstract

AIM: To establish a predictive nomogram for high-grade prostate cancer (HGPCa) in biopsy-naive patients based on the Prostate Imaging-Reporting and Data System version 2 (PI-RADS v2), magnetic resonance imaging (MRI)-based prostate volume (PV), MRI-based PV-adjusted prostate-specific antigen density (PSAD), and other classical parameters.
MATERIAL AND METHODS: Between August 2014 and August 2015, 158 men who were eligible for analysis were included as the training cohort. A prediction model for HGPCa was built using backward logistic regression and was presented on a nomogram. The prediction model was evaluated by a validation cohort between September 2015 and March 2016 (n=89). Histology of all lesions was obtained with MRI-directed transrectal ultrasound (TRUS)-guided targeted and sectoral biopsy.
RESULTS: The multivariate analysis revealed that patient age, PI-RADS v2 score, and adjusted PSAD were independent predictors for HGPCa. The most discriminative cut-off value for the logistic regression model was 0.33; the sensitivity, specificity, positive predictive value, and negative predictive value were 83.3%, 87.4%, 88.4%, and 81.2%, respectively. The diagnostic performance measures retained similar values in the validation cohort (AUC=0.83).
CONCLUSION: The nomogram for forecasting HGPCa is effective and potentially reducing harm from unnecessary prostate biopsy and over-diagnosis.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28069159     DOI: 10.1016/j.crad.2016.12.005

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  14 in total

Review 1.  PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Authors:  Anwar R Padhani; Jelle Barentsz; Geert Villeirs; Andrew B Rosenkrantz; Daniel J Margolis; Baris Turkbey; Harriet C Thoeny; François Cornud; Masoom A Haider; Katarzyna J Macura; Clare M Tempany; Sadhna Verma; Jeffrey C Weinreb
Journal:  Radiology       Date:  2019-06-11       Impact factor: 11.105

2.  Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

Authors:  Matthew D Greer; Joanna H Shih; Nathan Lay; Tristan Barrett; Leonardo Bittencourt; Samuel Borofsky; Ismail Kabakus; Yan Mee Law; Jamie Marko; Haytham Shebel; Maria J Merino; Bradford J Wood; Peter A Pinto; Ronald M Summers; Peter L Choyke; Baris Turkbey
Journal:  AJR Am J Roentgenol       Date:  2019-03-27       Impact factor: 3.959

3.  Nomogram based on MRI can preoperatively predict brain invasion in meningioma.

Authors:  Jing Zhang; Yuntai Cao; Guojin Zhang; Zhiyong Zhao; Jianqing Sun; Wenyi Li; Jialiang Ren; Tao Han; Junlin Zhou; Kuntao Chen
Journal:  Neurosurg Rev       Date:  2022-09-30       Impact factor: 2.800

4.  Development and Validation of a Model for Predicting the Risk of Death in Patients with Acinetobacter baumannii Infection: A Retrospective Study.

Authors:  Hui Zhang; Yayun Zhao; Yahong Zheng; Qinxiang Kong; Na Lv; Yanyan Liu; Dongmei Zhao; Jiabin Li; Ying Ye
Journal:  Infect Drug Resist       Date:  2020-08-10       Impact factor: 4.003

5.  Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients.

Authors:  Hyunsoo Ryoo; Min Yong Kang; Hyun Hwan Sung; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Hwang Gyun Jeon
Journal:  Prostate Int       Date:  2020-04-01

6.  Development and internal validation of PI-RADs v2-based model for clinically significant prostate cancer.

Authors:  Yu Zhang; Na Zeng; Yi Chen Zhu; Yang Xin Rui Huang; Qiang Guo; Ye Tian
Journal:  World J Surg Oncol       Date:  2018-06-01       Impact factor: 2.754

7.  A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions.

Authors:  Lei Liang; Xin Zhi; Ya Sun; Huarong Li; Jiajun Wang; Jingxu Xu; Jun Guo
Journal:  Front Oncol       Date:  2021-03-02       Impact factor: 6.244

8.  Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI.

Authors:  Mengjuan Li; Tong Chen; Wenlu Zhao; Chaogang Wei; Xiaobo Li; Shaofeng Duan; Libiao Ji; Zhihua Lu; Junkang Shen
Journal:  Quant Imaging Med Surg       Date:  2020-02

9.  A PI-RADS-Based New Nomogram for Predicting Clinically Significant Prostate Cancer: A Cohort Study.

Authors:  Yueyue Zhang; Guiqi Zhu; Wenlu Zhao; Chaogang Wei; Tong Chen; Qi Ma; Yongsheng Zhang; Boxin Xue; Junkang Shen
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

10.  Development and validation of a risk-prediction nomogram for patients with ureteral calculi associated with urosepsis: A retrospective analysis.

Authors:  Ming Hu; Xintai Zhong; Xuejiang Cui; Xun Xu; Zhanying Zhang; Lixian Guan; Quanyao Feng; Yiheng Huang; Weilie Hu
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.